4D Molecular raises $90M series B

Gene therapy company 4D Molecular Therapeutics Inc. (Emeryville, Calif.) raised $90 million in an untranched series B round led

Read the full 198 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE